Cashu
HeartBeam Innovates Cardiac Care with New Funding and Cable-Free ECG Technology
10 months ago
Stocks
Health Care
beat
HeartBeam
NASDAQ: BEAT
-0.02 (-0.73%)
3.415
USD
At close at Dec 17, 16:15 UTC
Overview
Loading chart...
Key Stats
Market Cap
118.03M
Dividend Yield
0.00%
P/E Ratio
-5.72
EPS
-0.74
Revenue
-
Avg. Volume
112.35M
About
What does BEAT do?
HeartBeam, a development stage company based in Santa Clara, California, focuses on advanced cardiovascular diagnostic technology and went public on October 14, 2021. They are developing proprietary VECG technology and two patented products, HeartBeam AIMI and HeartBeam AIMIGo, for cardiac disease detection and monitoring.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.